c ebpalpha and hepatic lipid

c ebpalpha and hepatic lipid Item - Depicted pathway for the exacerbated steatosis caused by combined treatment. - Public Library of Science C/EBPα-mediated ACSL4-dependent ferroptosis exacerbates tubular

Name: c ebpalpha and hepatic lipid Item - Depicted pathway for the exacerbated steatosis caused by combined treatment. - Public Library of Science C/EBPα-mediated ACSL4-dependent ferroptosis exacerbates tubular
Brand: aimoneimmobiliare.it
SKU: 4550403526
Price: 24.05 USD
Availability: InStock
Rating: 4.7272 (14 reviews)

C EBP mediated ACSL4 dependent ferroptosis exacerbates tubular injury in diabetic kidney disease Cell Death Discovery Crosstalk between Lipids and Non Alcoholic Fatty Liver Disease JCI Hepatocyte specific CCAAT enhancer binding protein restricts liver fibrosis progression A novel C EBPmiR 335 5pPRKAA2 regulatory axis drives hepatic lipid accumulation in MASLD Scientific Reports High dietary Fructose Drives Metabolic Dysfunction Associated Steatotic Liver Disease via Activating ubiquitin specific peptidase 2 11 hydroxysteroid dehydrogenase type 1 Pathway in Mice

SKU: 4550403526 · From aimoneimmobiliare.it

4.7

USD24.05 USD45.05

Pay in 4 interest-free payments of $6.01 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

Description

One of the earliest functional neuroimaging studies that implicated dopaminergic regions in fatigue used positron emission tomography (PET) to assess differences in brain activity at rest (i.e., without task) in individuals with MS ( Functional magnetic resonance imaging (fMRI) studies further support the dopamine imbalance hypothesis